nominally significantp < 0.05
We then performed a pathway enrichment analysis on all 353 nominally significant ( p < 0.05) genes from the burden test (i.e., CVM-associated genes).
We then performed a pathway enrichment analysis on all 353 nominally significant ( p < 0.05) genes from the burden test (i.e., CVM-associated genes).